{"id":400258,"date":"2025-05-09T09:37:53","date_gmt":"2025-05-09T07:37:53","guid":{"rendered":"https:\/\/medizinonline.com\/neue-dosierungsempfehlung-fuer-cetuximab-erlaubt-mehr-flexibilitaet-bei-verabreichung-1\/"},"modified":"2025-05-09T11:23:07","modified_gmt":"2025-05-09T09:23:07","slug":"les-nouvelles-recommandations-posologiques-pour-le-cetuximab-permettent-une-plus-grande-flexibilite-lors-de-ladministration-1","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/les-nouvelles-recommandations-posologiques-pour-le-cetuximab-permettent-une-plus-grande-flexibilite-lors-de-ladministration-1\/","title":{"rendered":"Les nouvelles recommandations posologiques pour le c\u00e9tuximab permettent une plus grande flexibilit\u00e9 lors de l\u2019administration [1]"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p><strong>Depuis le 28.02.2025, une nouvelle recommandation posologique est autoris\u00e9e en Suisse pour l\u2019inhibiteur de l\u2019EGFR c\u00e9tuximab : d\u00e9sormais, le c\u00e9tuximab peut \u00eatre administr\u00e9 toutes les deux&nbsp;semaines (Q2W) au lieu de toutes les semaines (Q1W) en cas de carcinome colorectal m\u00e9tastatique (mCRC, <em>metastasized ColoRectal Carcinoma<\/em>) et de carcinome \u00e9pidermo\u00efde r\u00e9cidivant ou m\u00e9tastatique (R\/M) de la r\u00e9gion t\u00eate et cou (SCCHN, <em>Squamous Cell Carcinoma of the Head and Neck<\/em>)<sup>*<\/sup>. [1]<\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-nouvelles-recommandations-posologiques-pour-le-cetuximab-permettent-une-plus-grande-flexibilite-lors-de-ladministration-1%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Depuis le 28.02.2025, une nouvelle recommandation posologique est autoris\u00e9e en Suisse pour l\u2019inhibiteur de l\u2019EGFR c\u00e9tuximab : d\u00e9sormais, le c\u00e9tuximab peut \u00eatre administr\u00e9 toutes les deux&nbsp;semaines (Q2W) au lieu de&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fles-nouvelles-recommandations-posologiques-pour-le-cetuximab-permettent-une-plus-grande-flexibilite-lors-de-ladministration-1%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":14,"featured_media":400221,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Sponsored Content: Anti-EGFR Therapien","footnotes":""},"category":[11549,11523,11345,11389],"tags":[],"powerkit_post_featured":[],"class_list":["post-400258","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-actualites","category-contenu-des-partenaires","category-oncologie","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-24 06:23:52","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/400258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=400258"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/400258\/revisions"}],"predecessor-version":[{"id":400279,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/400258\/revisions\/400279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/400221"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=400258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=400258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=400258"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=400258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}